Business
Spectral Diagnostics provides update on results of annual and special meeting
TORONTO , May 23, 2013 /CNW/ - Spectral Diagnostics Inc. (TSX: SDI) (OTC QX: DIAGF) (t...
About this update from Spectral Medical Inc
[{"type":"text","content":"\n\n\nTORONTO, May 23, 2013 /CNW/ - Spectral Diagnostics Inc. (TSX: SDI) (OTC QX: DIAGF) (the \"Corporation\") today announced that Mr. Anthony Bihl has been appointed as the\n Chairman of the board.  The Corporation also notes that at the annual\n and special meeting of shareholders that was held earlier today, all\n eight nominees for the board were elected as a matter of corporate law,\n however, two of the directors received a greater number of votes\n withheld than votes in favour.  Pursuant to the Majority Voting Policy\n of the Corporation, those two directors have each tendered their\n resignations as directors, effective only on acceptance by the board.\n Full details are contained in the Report of Voting Results for the\n Meeting which has been filed on Sedar at www.Sedar.com.\n\n\nPursuant to the Majority Voting Policy, the board has convened and\n referred the resignations to an ad hoc nominating committee to consider\n whether to accept or reject such resignations.  The Corporation will\n announce the results of the ad hoc nominating committee's\n recommendation and board's determination once this matter has been\n concluded.\n\n\nAbout Spectral Diagnostics\n\n\nSpectral is a Phase III company seeking U.S. FDA approval for its lead\n theranostics product (Toraymyxin) for the treatment of septic shock.\n Toraymyxin is a therapeutic hemoperfusion device that removes\n endotoxin, which can cause sepsis, from the bloodstream. Directed by\n the Company's Endotoxin Activity Assay (EAA™), the only FDA-cleared\n diagnostic for the risk of developing sepsis, Spectral's EUPHRATES\n trial is the world's first theranostics trial in the area of sepsis.\n\n\nSpectral is listed on the Toronto Stock Exchange under the symbol SDI,\n and on the OTC QX under the symbol DIAGF. For more information please\n visit www.spectraldx.com\n\n\nForward-looking statement\n\n\nInformation in this news release that is not current or historical\n factual information may constitute forward looking information within\n the meaning of securities laws. Implicit in this information,\n particularly in respect of the future outlook of Spectral and\n anticipated events or results, are assumptions based on beliefs of\n Spectral's senior management as well as information currently available\n to it. While these assumptions were consider...